Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Blood Collection Market was valued at approximately USD 10.9 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2032. Blood collection is crucial in healthcare for diagnosis, treatment, and research, involving venipuncture, fingerstick, or arterial draws. The market is driven by the rising prevalence of chronic diseases like cardiovascular ailments, diabetes, respiratory issues, and cancer. Technological advancements, an increase in surgical procedures, and a growing geriatric population further fuel market growth. Automated blood collection systems reduce human error and enhance patient comfort. These systems, including automated venipuncture devices, use robotics and advanced imaging for precise and consistent blood draws.

The overall blood collection industry is classified based on the vehicle, product type, capillary, method, application, end-use and region.

The market is segmented by product type into venous and capillary. The venous segment includes needles and syringes, blood collection tubes, blood bags, and other products. The capillary segment includes lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other products. The venous segment is projected to reach USD 12.7 billion by 2032.

Venous blood collection yields larger volumes, essential for comprehensive tests and multiple analyses. Venous samples support a wide range of diagnostic tests, including biochemistry, hematology, serology, and molecular diagnostics. They can be fractionated into plasma or serum for specialized tests. Venous samples are more consistent and reliable, crucial for accurate diagnostics and long-term studies. Venous samples face fewer issues like hemolysis and contamination compared to capillary samples.

The market is also segmented by method into manual and automated blood collection. The manual segment accounted for USD 7.1 billion in 2023. Manual techniques like venipuncture and fingerstick are easily performed with basic training, allowing quick responses to diverse patient needs. Manual tools, such as syringes, needles, and lancets, are portable and ideal for remote areas, home visits, or emergencies. Manual methods are cost-effective, requiring minimal equipment, making them viable for resource-limited settings.

The U.S. blood collection market is projected to reach USD 7.3 billion by 2032. The U.S. leads in healthcare technology and innovation, benefiting from advancements in blood collection technologies like automated venipuncture systems and microfluidic devices. The rising prevalence of chronic diseases, including cardiovascular ailments, diabetes, respiratory issues, and cancer, drives market growth. In 2020, the CDC reported 1,603,844 new cancer cases and 602,347 fatalities in the U.S.

Product Code: 10597

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of chronic and infectious diseases
  - 3.2.1.2 Advancements in blood collection technologies
  - 3.2.1.3 Increasing number of surgical procedures
  - 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of blood collection equipment
  - 3.2.2.2 Risks associated with blood transfusions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Venous
- 5.2.1 Needles and syringes
  - 5.2.1.1 Double-ended needles
  - 5.2.1.2 Winged blood collection sets
  - 5.2.1.3 Standard hypodermic needles
  - 5.2.1.4 Other blood collection needles
- 5.2.2 Blood collection tubes
  - 5.2.2.1 Serum-separating
  - 5.2.2.2 EDTA
  - 5.2.2.3 Heparin
  - 5.2.2.4 Plasma-separating
- 5.2.3 Blood bags
- 5.2.4 Other venous products
5.3 Capillary
- 5.3.1 Lancets
- 5.3.2 Micro-container tubes
- 5.3.3 Micro-hematocrit tubes
- 5.3.4 Warming devices
- 5.3.5 Other capillary products

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Manual blood collection
6.3 Automated blood collection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Diagnostics
7.3 Treatment
7.4 Research

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic centers
8.4 Blood banks
8.5 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Cardinal Health, Inc.
10.4 F. Hoffmann-La Roche Ltd.
10.5 FL MEDICAL s.r.l.
10.6 Fresenius SE and Co. KGaA
10.7 Haemonetics Corporation
10.8 Greiner AG
10.9 McKESSON CORPORATION
10.10 Medtronic plc
10.11 Nipro Corporation
10.12 QIAGEN N.V.
10.13 Sarstedt AG and Co. KG
10.14 Siemens Healthineers AG
10.15 Terumo Corporation
10.16 Thermo Fisher Scientific Inc.